Center for Immunobiology and Vaccine Development, Children’s Hospital Oakland Research Institute, Oakland, California, USA.
J Bacteriol. 2012 Feb;194(3):617-26. doi: 10.1128/JB.06268-11. Epub 2011 Nov 28.
Lateral gene transfer (LGT) is essential for generating between-strain genomic recombinants of Chlamydia trachomatis to facilitate the organism's evolution. Because there is no reliable laboratory-based gene transfer system for C. trachomatis, in vitro generation of recombinants from antibiotic-resistant strains is being used to study LGT. However, selection pressures imposed on in vitro recombinants likely affect statistical properties of recombination relative to naturally occurring clinical recombinants, including prevalence at particular loci. We examined multiple loci for 16 in vitro-derived recombinants of ofloxacin- and rifampin-resistant L(1) and D strains, respectively, grown with both antibiotics, and compared these with the same sequenced loci among 11 clinical recombinants. Breakpoints and recombination frequency were examined using phylogenetics, bioinformatics, and statistics. In vitro and clinical isolates clustered perfectly into two groups, without misclassification, using Ward's minimum variance based on breakpoint data. As expected, gyrA (confers ofloxacin resistance) and rpoB (confers rifampin resistance) had significantly more breakpoints among in vitro recombinants than among clinical recombinants (P < 0.0001 and P = 0.02, respectively, using the Wilcoxon rank sum test). Unexpectedly, trpA also had significantly more breakpoints for in vitro recombinants (P < 0.0001). There was also significant selection at other loci. The strongest bias was for ompA in strain D (P = 3.3 × 10(-8)). Our results indicate that the in vitro model differs statistically from natural recombination events. Additional genomic studies are needed to determine the factors responsible for the observed selection biases at unexpected loci and whether these are important for LGT to inform approaches for genetically manipulating C. trachomatis.
水平基因转移(LGT)对于生成沙眼衣原体菌株间的基因组重组体至关重要,有助于该生物的进化。由于没有用于沙眼衣原体的可靠实验室基因转移系统,因此正在使用来自抗生素抗性株的体外重组体来研究 LGT。然而,对体外重组体施加的选择压力可能会影响与自然发生的临床重组体相关的重组的统计特性,包括在特定基因座的流行率。我们检查了 16 个来自氟氧沙星和利福平抗性 L(1)和 D 株的体外衍生重组体的多个基因座,这些重组体分别用两种抗生素培养,并将这些重组体与 11 个临床重组体中的相同测序基因座进行了比较。使用系统发生学、生物信息学和统计学检查了断点和重组频率。在基于断点数据的 Ward 最小方差的基础上,体外和临床分离株完美地聚类成两组,没有错误分类。正如预期的那样,gyrA(赋予氟氧沙星抗性)和 rpoB(赋予利福平抗性)在体外重组体中比在临床重组体中有更多的断点(Wilcoxon 秩和检验,P < 0.0001 和 P = 0.02)。出乎意料的是,trpA 在体外重组体中也有更多的断点(P < 0.0001)。其他基因座也存在显著的选择。在 D 株中,ompA 的偏倚最强(P = 3.3 × 10(-8))。我们的结果表明,体外模型在统计学上与自然重组事件不同。需要进行更多的基因组研究,以确定导致在意外基因座观察到的选择偏差的因素,以及这些因素是否对 LGT 很重要,以指导操纵沙眼衣原体的遗传方法。